2016-06-06
Proteo receives US$ 1 million grant for a new Elafin drug formulation
The Company's focus is on the development of anti-inflammatory treatments for rare diseases with significant unmet needs. Proteo is engaged in the development of pharmaceuticals based on the body's own tools and weapons to fight inflammatory diseases.
